CoChat
Sign Up
Cited by 5

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Anti-CRISPR: A defense strategy of bacteriophages against bacteria

S, Anandu, Tanuj, GN·2020·Journal of Entomology and Zoology Studies
DOI 10.22271/j.ento.2020.v8.i6n.7968
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.22271/j.ento.2020.v8.i6n.7968

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 72

  1. Seed KD. Battling Phages: How Bacteria Defend against Viral Attack. PLOS Pathogens 2015;11(6):e1004847. https://doi.org/10.1371/journal.ppat.1004847 · DOI
  2. Mojica FJM, Dίez-Villaseñor C, Garcίa-Martίnez J, Soria E. Intervening Sequences of Regularly Spaced Prokaryotic Repeats Derive from Foreign Genetic Elements. Journal of Molecular Evolution 2005;60(2):174-182. https://doi.org/10.1007/s00239-004- 0046-3 · DOI · Paper page
  3. Horvath P, Romero DA, Couˆte´-Monvoisin AC et al. Diversity, activity, and evolution of CRISPR loci in Streptococcus thermophilus. J Bacteriol 2008;190:1401- 1412. https://doi.org/10.1128/JB.01415-07 · DOI
  4. Jiang F, Doudna JA. CRISPR-Cas9 Structures and Mechanisms. Annual Review of Biophysics 2017;46(1):505-529. https://doi.org/10.1146/annurev- biophys-062215-010822 · DOI · Paper page
  5. Makarova KS, Wolf YI, Alkhnbashi OS, Costa F, Shah SA, Saunders SJ et al. An updated evolutionary classification of CRISPR-Cas systems. Nat. Rev. Microbiol 2015;13:722-736. https://doi.org/10.1038/nrmicro3569 · DOI · Paper page
  6. Pawluk A, Davidson AR, Maxwell K. Anti-CRISPR: discovery, mechanism and function. Nature reviews. Microbiology 2017;16(1):12-17. https://doi.org/10.1038/nrmicro. · DOI
  7. Garneau JE, Dupuis ME, Villion M, Romero DA, Barrangou R, Boyaval P, et al. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 2010;468(7320):67-71. https://doi.org/10.1038/nature09523 · DOI
  8. Maxwell KL. The Anti-CRISPR Story: A Battle for Survival. Molecular Cell 2017;68(1):8-14. https://doi.org/10.1016/j.molcel.2017.09.002 · DOI
  9. FJM Mojica C, Díez-Villaseñor J, García-Martínez C, Almendros. Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology 2009;155(3):733-740. https://doi.org/10.1099/mic.0.023960-0 · DOI · Paper page
  10. Peter C, Fineran, Matthias JH, Gerritzen, María, Suárez- Diez, Tim Künne, Jos Boekhorst, Sacha AFT, van Hijum, Raymond HJ, Staals and Stan JJ Brouns. Degenerate target sites mediate rapid primed CRISPR adaptation. Proceedings of the National Academy of Sciences 2014;111(16):E1629-E1638. https://doi.org/10.1073/pnas.1400071111 · DOI
  11. Bondy-Denomy J, Pawluk A, Maxwell KL et al. Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 2013;493:429-432. https://doi.org/10.1038/nature11723. · DOI
  12. Pawluk A, Bondy-Denomy J, Cheung VHW, Maxwell KL, Davidson AR. A New Group of Phage Anti-CRISPR Genes Inhibits the Type I-E CRISPR-Cas System of Pseudomonas aeruginosa. Mbio 2014,5(2). https://doi.org/10.1128/mbio.00896-14 · DOI
  13. Pawluk A et al. Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species. Nature Microbiology 2016;1(8). https://doi.org/10.1038/nmicrobiol.2016.85 · DOI
  14. Pawluk A et al. Naturally Occurring Off-Switches for CRISPR-Cas9 Cell 2016;167(7):1829-1838.e9. https://doi.org/10.1016/j.cell.2016.11.017 · DOI
  15. Lee Mir J, et al. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins. mBio 2018;9(6). https://doi.org/10.1128/mbio.02321-18 · DOI
  16. Edgar Qimron R. The Escherichia coli CRISPR System Protects from Lysogenization, Lysogens and Prophage Induction. Journal of Bacteriology 192(23):6291-6294. https://doi.org/10.1128/jb.00644-10 · DOI
  17. Rauch BJ, Silvis MR, Hultquist JF, Waters CS, McGregor MJ, Krogan NJ. Inhibition of CRISPR-Cas9 with Bacteriophage Proteins. Cell 2017;168(1-2):150- 158.e10. https://doi.org/10.1016/j.cell.2016.12.009 · DOI
  18. Hynes AP, Rousseau GM, Lemay ML, Horvath P, Romero DA, Fremaux C. An anti-CRISPR from a virulent streptococcal phage inhibits Streptococcus pyogenes Cas9. Nature Microbiology 2017;2(10):1374- 1380. https://doi.org/10.1038/s41564-017-0004-7 · DOI
  19. Hynes AP et al. Widespread anti-CRISPR proteins in virulent bacteriophages inhibit a range of Cas9 proteins. Nature Communications 2018;9(1). https://doi.org/10.1038/s41467-018-05092-w · DOI
  20. Marshall et al. Rapid and Scalable Characterization of CRISPR Technologies Using an E. coli Cell-Free Transcription-Translation System. Molecular Cell 2018;69(1):146-157.e3. https://doi.org/10.1016/j.molcel.2017.12.007 · DOI
  21. He F, Bhoobalan-Chitty, Y et al. Anti-CRISPR proteins encoded by archaeal lytic viruses inhibit subtype I-D immunity. Nature Microbiology 2018;3(4):461-469. https://doi.org/10.1038/s41564-018-0120-z · DOI
  22. Marino ND et al. Discovery of widespread Type I and Type V CRISPR-Cas inhibitors. Science, 2018, eaau5174. https://doi.org/10.1126/science.aau5174 · DOI
  23. Watters KE, Fellmann C, Bai HB, Ren SM, Doudna JA. Systematic discovery of natural CRISPR-Cas12a inhibitors. Science, 2018, eaau5138. https://doi.org/10.1126/science.aau5138 · DOI
  24. Bland TL, Ramsey F, Sabree M, Lowe Brown K, Kyrpides NC, Hugenholtz. CRISPR recognition tool (CRT): A tool for automatic detection of clustered regularly interspaced palindromic repeats. BMC Bioinformatics 2007. https://doi.org/10.1186/1471-2105- 8-209 Medline · DOI
  25. Uribe RV, van der Helm E, Misiakou MA, Lee SW, Kol S, Sommer MOA. Discovery and Characterization of Cas9 Inhibitors Disseminated across Seven Bacterial Phyla. Cell Host & Microbe 2019. https://doi.org/10.1016/j.chom.2019.01.003 · DOI
  26. Forsberg KJ et al Functional metagenomics-guided discovery of potent Cas9 inhibitors in the human microbiome. Elife 2019. https://doi.org/10.7554/eLife.46540 · DOI
  27. Osuna et al. Listeria phages induce Cas9 degradation to protect lysogenic genomes. bioRxiv 2019. https://doi.org/10.1101/787200 · DOI
  28. Watters et al. Potent CRISPR-Cas9 inhibitors from Staphylococcus genomes. PNAS. 2020;117(12):6531-6539. https://doi.org/10.1073/pnas.1917668117 · DOI
  29. Mahendra C, Christie KA, Osuna BA et al. Broad- spectrum anti-CRISPR proteins facilitate horizontal gene transfer. Nat Microbiol, 2020, 620-629. https://doi.org/10.1038/s41564-020-0692-2 · DOI
  30. Bhoobalan-Chitty Y, Johansen TB, Di Cianni N, Peng X. Inhibition of Type III CRISPR-Cas Immunity by an Archaeal Virus-Encoded Anti-CRISPR Protein. Cell. https://doi.org/10.1016/j.cell.2019.09.003 · DOI
  31. Athukoralage JS et al. An anti-CRISPR viral ring nuclease subverts type III CRISPR immunity. Nature 2020;577(7791):572-575. https://doi.org/10.1038/s41586-019-1909-5 · DOI
  32. Smargon AA et al. Cas13b Is a Type VI-B CRISPR- Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28. Molecular Cell 2017;65(4):618-630.e7. https://doi.org/10.1016/j.molcel.2016.12.023 · DOI · Paper page
  33. Marino ND, Pinilla-Redondo R, Csörgő B, Bondy- Denom J. Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies. Nature Methods 2020. https://doi.org/10.1038/s41592-020-0771-6 · DOI
  34. Hwang S, Maxwell KL. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems. The CRISPR Journal 2019;2(1):23-30. https://doi.org/10.1089/crispr.2018.0052 · DOI
  35. Davidson AR et al. Anti-CRISPRs: Protein Inhibitors of CRISPR-Cas Systems. Annual Review of Biochemistry 2020,89(1). https://doi.org/10.1146/annurev-biochem- 011420-111224 · DOI
  36. Bondy-Denomy et al. A Unified Resource for Tracking Anti-CRISPR Names. The CRISPR Journal 2018;1(5):304-305. https://doi.org/10.1089/crispr.2018.0043 · DOI
  37. Dong C, Hao GF, Hua HL, Liu S, Labena AA, Chai G et al. Anti-CRISPRdb: a comprehensive online resource for anti-CRISPR proteins. Nucleic acids research 2018;46(D1):D393-D398. https://doi.org/10.1093/nar/gkx835 · DOI
  38. Trasanidou D, Gerós AS, Mohanraju P, Nieuwenweg AC, Nobrega FL, Staals RHJ. Keeping crispr in check: diverse mechanisms of phage-encoded anti-crisprs. FEMS Microbiology Letters 2019;366(9). https://doi.org/10.1093/femsle/fnz098 · DOI
  39. Zhu Y, Zhang F, Huang Z. Structural insights into the inactivation of CRISPR-Cas systems by diverse anti- CRISPR proteins. BMC Biol 2018;16:32. https://doi.org/10.1186/s12915-018-0504-9 · DOI
  40. Peng R, Xu Y, Zhu T, Li N, Qi J, Chai Y, et al. Alternate binding modes of anti-CRISPR viral suppressors AcrF1/2 to Csy surveillance complex revealed by cryo-EM structures. Cell research 2017;27(7):853-864. https://doi.org/10.1038/cr.2017.79 · DOI
  41. Guo TW, Bartesaghi A, Yang H, Falconieri V, Rao P, Merk A et al. Cryo-EM Structures Reveal Mechani csm and Inhibition of DNA Targeting by a CRISPR-Cas Surveillance Complex. Cell 2017;171(2):414-426.e12. https://doi.org/10.1016/j.cell.2017.09.006 · DOI
  42. Wang X, Yao D, Xu J et al. Structural basis of Cas3 inhibition by the bacteriophage protein AcrF3. Nat Struct Mol Biol 2016;23:868-870 https://doi.org/10.1038/nsmb.3269 · DOI
  43. Vorontsova D, Datsenko KA, Medvedeva S, Bondy- Denomy J, Savitskaya EE, Pougach K et al. Foreign DNA acquisition by the I-F CRISPR-Cas system requires all components of the interference machinery.Nucleic acids research 2015;43(22):10848-10860. https://doi.org/10.1093/nar/gkv1261 · DOI
  44. Rollins MF, Chowdhury S, Carter J, Golden SM, Wilkinson RA, Bondy-Denomy J et al. Cas1 and the Csy complex are opposing regulators of Cas2/3 nuclease activity. Proceedings of the National Academy of Sciences of the United States of America 2017;114(26):E5113-E5121. https://doi.org/10.1073/pnas.1616395114 · DOI
  45. Pawluk A, Shah M, Mejdani M, Calmettes C, Moraes TF, Davidson AR et al. Disabling a Type I-E CRISPR-Cas Nuclease with a Bacteriophage-Encoded Anti-CRISPR Protein. mBio 2017;8(6):e01751-17. https://doi.org/10.1128/mBio.01751-17 · DOI
  46. Jiang F, Taylor DW, Chen JS, Kornfeld JE, Zhou K, Thompson AJ et al. Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage. Science (New York, N.Y.) 2016;351(6275):867-871. https://doi.org/10.1126/science.aad8282 · DOI
  47. Dong D, Guo M, Wang S et al. Structural basis of CRISPR-SpyCas9 inhibition by an anti-CRISPR protein. Nature 2017;546:436-439. https://doi.org/10.1038/nature22377 · DOI
  48. Yang H, Patel DJ. Inhibition Mechanism of an Anti- CRISPR Suppressor AcrIIA4 Targeting SpyCas9. Molecular cell 2017;67(1):117-127.e5. https://doi.org/10.1016/j.molcel.2017.05.024 · DOI
  49. Shin J, Jiang F, Liu JJ, Bray NL, Rauch BJ, Baik SH. Disabling Cas9 by an anti-CRISPR DNA mimic. Science advances 2017;3(7):e1701620. https://doi.org/10.1126/sciadv.1701620 · DOI
  50. Liu L, Yin M, Wang M, Wang Y. Phage AcrIIA2 DNA Mimicry: Structural Basis of the CRISPR and Anti- CRISPR Arms Race. Molecular Cell 2018. https://doi.org/10.1016/j.molcel.2018.11.011 · DOI
  51. Jiang F, Liu JJ, Osuna BA et al. Temperature-responsive compet tive inhibition of CRISPR-Cas9. Mol Cell 2019;73:601-10e605. https://doi.org/10.1016/j.molcel.2018.11.016 · DOI
  52. Zhu Y, Gao A, Zhan Q, Wang Y, Feng H, Liu S et al. Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins. Molecular cell 2019;74(2):296-309.e7. https://doi.org/10.1016/j.molcel.2019.01.038 · DOI
  53. Harrington LB, Doxzen KW, Ma E, Liu JJ, Knott GJ, Edraki A et al. A Broad-Spectrum Inhibitor of CRISPR- Cas9. Cell 2017;170(6):1224-1233.e15. https://doi.org/10.1016/j.cell.2017.07.037 · DOI
  54. Zhang H, Li Z, Daczkowski CM, Gabel C, Mesecar AD, Chang L. Structural Basis for the Inhibition of CRISPR- Cas12a by Anti-CRISPR Proteins. Cell Host & Microbe 2019. https://doi.org/10.1016/j.chom.2019.05.004 · DOI
  55. Dong L, Guan X, Li N et al. An anti-CRISPR protein disables type V Cas12a by acetylation. Nat Struct Mol Biol 2019;26:308-314 https://doi.org/10.1038/s41594- 019-0206-1 · DOI
  56. Knott GJ, Thornton BW, Lobba MJ, Liu JJ, Al-Shayeb B, Watters KE. Broad-spectrum enzymatic inhibition of CRISPR-Cas12a. Nature structural & molecular biology 2019;26(4):315-321. https://doi.org/10.1038/s41594-019- 0208-z · DOI
  57. Fuchsbauer O et al. Cas9 Allosteric inhibition by the anti-CRISPR proteinAcrIIA6. Mol. Cell 2019;76:922- 937.e7. https://doi.org/10.1016/j.molcel.2019.09.012 · DOI
  58. Haidong Yi, Le Huang, Bowen Yang, Javi Gomez, Han Zhang, Yanbin Yin. AcrFinder: genome mining anti- CRISPR operons in prokaryotes and their viruses, Nucleic Acids Research 2020,351. https://doi.org/10.1093/nar/gkaa351 · DOI
  59. Eitzinger S, Asif A, Watters KE, Iavarone AT, Knott GJ, Doudna JA. Machine learning predicts new anti-CRISPR proteins.Nucleic acids research 2020;48(9):4698-4708. https://doi.org/10.1093/nar/gkaa219 · DOI
  60. Lin et al. CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells, Molecular Cell 2020. https://doi.org/10.1016/j.molcel.2020.03.033 · DOI
  61. Gussow AB, Shmakov SA, Makarova KS, Wolf YI, Bondy-Denomy J, Koonin EV. Vast diversity of anti- CRISPR proteins predicted with a machine-learning approach. BioRxiv. 2020;2020.01.23.916767. https://doi.org/10.1101/2020.01.23.916767 · DOI
  62. Zhang F, Zhao S, Ren C et al. CRISPRminer is a knowledge base for exploring CRISPR-Cas systems in microbe and phage interactions.Commun Biol. 2018; 180. https://doi.org/10.1038/s42003-018-0184-6 · DOI
  63. Knott GJ, Cress BF, Liu JJ, Thornton BW, Lew RJ et al. Structural basis for AcrVA4 inhibition of specific CRISPR-Cas12a. eLife 2019;8:e49110. https://doi.org/10.7554/eLife.49110 · DOI
  64. Nakamura M, Srinivasan P, Chavez M, Carter MA, Dominguez AA et al. Anti-CRISPR-mediated control of gene editing and synthetic circuits in eukaryotic cells.Nat. Commun 2019;10:194. https://doi.org/10.1038/s41467- 018-08158-x · DOI
  65. Nobrega FL, Costa AR, Kluskens LD, Azeredo J. Revisiting phage therapy: new applications for old resources.Trends Microbiol 2015;23:185-91. https://doi.org/10.1016/j.tim.2015.01.006 · DOI
  66. Bubeck F, Hoffmann MD, Harteveld Z et al. Engineered ant CRISPR proteins for optogenetic control of CRISPR-Cas9. Nature methods 2018;15(11):924-927. https://doi.org/10.1038/s41592-018-0178-9 · DOI
  67. Mayo-Muñoz D, He F, Jørgensen JB, Madsen PK, Bhoobalan-Chitty Y, Peng X. Anti-CRISPR-Based and CRISPR-Based Genome Editing of Sulfolobus islandicus Rod-Shaped Virus 2. Viruses 2018;10(12):695. https://doi.org/10.3390/v10120695 · DOI
  68. Basgall EM, Goetting SC, Goeckel ME et al. Gene drive inhibition by the anti-CRISPR proteins AcrIIA2 and AcrIIA4 in Saccharomyces cerevisiae. Microbiology 2018;164(4):464-474. https://doi.org/10.1099/mic.0.000635 · DOI
  69. Shin J, Jiang F, Liu JJ, et al. Disabling Cas9 by an anti- CRISPR DNA mimic. Science advances 2017;3(7):e1701620. https://doi.org/10.1126/sciadv.1701620 · DOI
  70. Hirosawa M, Fujita Y, Parr CJC et al. Cell-type-specific genome editing with a microRNA-responsive CRISPR- Cas9 switch. Nucleic acids research 2017;45(13):e118. https://doi.org/10.1093/nar/gkx309 · DOI
  71. Lee J, Mou H, Ibraheim R et al. Tissue-restricted genome editing in vivo specified by microRNA-repressible anti- CRISPR proteins. RNA 2019;25(11):1421-1431. https://doi.org/10.1261/rna.071704.119 · DOI · Paper page
  72. Palmer DJ, Turner DL, Ng P et al. Production of CRISPR/Cas9-Mediated Self-Cleaving Helper Dependent Adenoviruses. Molecular therapy. Methods & clinical development 2019;13:432-439. https://doi.org/10.1016/j.omtm.2019.04.003 · DOI

Cited by

Sorted by citations

See all 5

Metadata

Authors
S, A., & Tanuj, G.
Venue
Journal of Entomology and Zoology Studies
Publisher
AkiNik Publications
Published
2020-11-01
Volume
8
Issue
6
Pages
1003-1010
ISSN
  • 2349-6800
  • 2320-7078
DOI
10.22271/j.ento.2020.v8.i6n.7968
Cited by
5
References
2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review